1. Under the 'CRS: a clinical overview' sub-heading of the background, the sentence at the end of the second paragraph should instead read as the following: 'The ability to discontinue the drug before prolonged CRS occurs, the use of CTCAE grading, and the potency of the therapy likely all contributed to the low rates of CRS observed (2% of patients experienced grade 3 CRS).'
2. Under the 'CTCAE scale' sub-heading of the background, the sentence at the beginning of the section should instead read as the following: 'The CTCAE CRS grading scale was modified to define mild, moderate, severe, and life-threatening CRS, regardless of the inciting agent, and to guide treatment recommendations [36] .' 3. In Table 2 [4] in this correction article.
